Elijah Behr (@behrelijah) 's Twitter Profile
Elijah Behr

@behrelijah

Professor of Cardiovascular Medicine, Consultant Cardiologist and Electrophysiologist researching sudden death, genetics and genomics.

ID: 1080566620899160082

calendar_today02-01-2019 20:48:53

1,1K Tweet

1,1K Takipçi

346 Takip Edilen

Europace Editor-in-Chief (@europaceeic) 's Twitter Profile Photo

From all of us at #Europace, we wish you a joyful holiday season and a happy New Year! 🎄✨ 🙏🏻A heartfelt thank you to our Editorial Board, Reviewers, and Readers. Together, we look forward to continuing to advance science and care in 2025 !❤️ academic.oup.com/europace

From all of us at #Europace, we wish you a joyful holiday season and a happy New Year! 🎄✨ 

🙏🏻A heartfelt thank you to our Editorial Board, Reviewers, and Readers. Together, we look forward to continuing to advance science and care in 2025 !❤️

academic.oup.com/europace
Elijah Behr (@behrelijah) 's Twitter Profile Photo

Last chance for fantastic opportunity in cardiac ion channel disease - Lecturer in Cardiovascular Sciences jobs.sgul.ac.uk/108-24-R

CRY (@cry_uk) 's Twitter Profile Photo

#CRYResearch Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents #YSCD Prof Michael Papadakis Elijah Behr Stathis Papatheodorou Gherardo Finocchiaro CRY Cardiac Path Sanjay Sharma academic.oup.com/eurjpc/advance…

Jose Luis Merino (@joselmerino) 's Twitter Profile Photo

🚨 Great news! The Late-Breaking Clinical Trial (LBCT) submission deadline for EHRA 2025 has been extended to Thursday, 30 January 2025 (23:59 CET)! ⏳ Don't miss this chance to showcase your groundbreaking research! #EHRA2025 #LBCT EHRAPresident Stelios Tzeis

🚨 Great news! 
The Late-Breaking Clinical Trial (LBCT) submission deadline for EHRA 2025 has been extended to Thursday, 30 January 2025 (23:59 CET)! ⏳
 
Don't miss this chance to showcase your groundbreaking research! 
#EHRA2025 #LBCT <a href="/EHRAPresident/">EHRAPresident</a> <a href="/SteliosTzeis/">Stelios Tzeis</a>
Journal of Cardiac Failure (@jcardfail) 's Twitter Profile Photo

Current guidelines for primary prev ICD might not apply to contemporary pts given advances in HF Rx. Or do they? 🌟 This joint publication in #JCF & HeartRhythm summarizes data to date and proposes clinical trial to reassess. 🔗 bit.ly/3CEUj7a

Current guidelines for primary prev ICD might not apply to contemporary pts given advances in HF Rx. Or do they?

🌟 This joint publication in #JCF &amp; <a href="/hrs_journal/">HeartRhythm</a> summarizes data to date and proposes clinical trial to reassess.

🔗 bit.ly/3CEUj7a
CRY (@cry_uk) 's Twitter Profile Photo

#CRYResearch Influence of age and sex on the diagnostic yield of inherited cardiac conditions in sudden arrhythmic death syndrome decedents #YSCD The aim was to investigate the impact of age & sex on the overall diagnostic yield & underlying aetiology in decedents with SADS

European Society of Cardiology (@escardio) 's Twitter Profile Photo

The clinical consensus statement on the diagnostic role of pharmacological provocation testing in cardiac #electrophysiology has just been published. Cheryl Teres discusses with document authors Elijah Behr and prof Jacob Tfelt-Hansen the key points of the document. Watch their

Prof Michael Papadakis (@michaelpapadak2) 's Twitter Profile Photo

Great case presentation of a young performer with arrhythmogenic cardiomyopathy presented by Mihnea Casian #ESCPrev2025 highlighting the challenges we face with managing the condition and exercise prescription. Sanjay Sharma Ruxandra Jurcut

Great case presentation of a young performer with arrhythmogenic cardiomyopathy presented by <a href="/MihneaCasian/">Mihnea Casian</a> #ESCPrev2025 highlighting the challenges we face with managing the condition and exercise prescription. <a href="/SSharmacardio/">Sanjay Sharma</a> <a href="/RJurcut/">Ruxandra Jurcut</a>
EHRAPresident (@ehrapresident) 's Twitter Profile Photo

Also, #EHRA_ESC Consensus on Pharmacological Provocation Testing was presented during #EHRA2025 chaired by Elijah Behr & prof Jacob Tfelt-Hansen, offering expert guidance on arrhythmic syndromes & SCD/SCA risk ⚡ It covers: 🧪 Na⁺ channel blockers 💉 Epinephrine, adenosine & ergonovine 🔑

Also, #EHRA_ESC Consensus on Pharmacological Provocation Testing was presented during #EHRA2025  chaired by <a href="/BehrElijah/">Elijah Behr</a> &amp; <a href="/JacobTfelt/">prof Jacob Tfelt-Hansen</a>, offering expert guidance on arrhythmic syndromes &amp; SCD/SCA risk ⚡

It covers:
🧪 Na⁺ channel blockers
💉 Epinephrine, adenosine &amp; ergonovine
🔑
Prof Michael Papadakis (@michaelpapadak2) 's Twitter Profile Photo

Are you a cardiology trainee who wishes to research and gain invaluable experience in the field of #SportsCardiology #screening #InheritedCardiacConditions #CardiacImaging to gain an MD/PhD? Then apply for a post School of Health & Medical Sciences sponsored by CRY jobs.sgul.ac.uk/112-25

Circulation (@circaha) 's Twitter Profile Photo

#CircatHRS25 subcutaneous implantable cardioverter-defibrillator (S-ICD) is superior to the transvenous ICD (TV-ICD) w/ respect to device-related complications during long-term follow-up & should be considered in all patients w/o an indication of pacing. ahajrnls.org/3YMmecU

#CircatHRS25  subcutaneous implantable cardioverter-defibrillator (S-ICD) is superior to the transvenous ICD (TV-ICD) w/ respect to device-related complications during long-term follow-up &amp; should be considered in all patients w/o an indication of pacing. ahajrnls.org/3YMmecU
Fu Siong Ng (@drfusiongng) 's Twitter Profile Photo

Cardiovascular disease (CVD) causes more than a quarter of UK deaths. Continued support for research is critical. I joined more than 60 ⁦British Heart Foundation⁩ funded-researchers in writing to the Government urging them to prioritise CVD in the Life Sciences Plan bhf.org.uk/what-we-do/new…